Our “disease first” approach to product discovery and development at 4DMT allows us to tailor our AAV vectors to target particular tissue types linked to the underlying condition. This is made possible by our revolutionary discovery platform, Therapeutic Vector Evolution.
4DMT
1 BILLION POSSIBILITIES FOR A CURE
- Description
- Contact Form
